Flare Measurements in Human Radiation Therapy Patients

ChromoLogic, LLC1 site in 1 country10 target enrollmentJuly 2012

ConditionsThe Impact of Whole Body Irradiation on Ocular Flare

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: The Impact of Whole Body Irradiation on Ocular Flare
Sponsor: ChromoLogic, LLC
Enrollment: 10
Locations: 1
Primary Endpoint: Ocular flare in radiotherapy patients
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a longitudinal Feasibility Study of a novel non-invasive device in assessing radiation dose exposure in humans. All patients receiving whole body irradiation therapy and meeting all other inclusion/exclusion criteria will receive ocular flare meter measurements and slit-lamp examinations on up to eleven occasions starting prior to the first fractional dose of irradiation.

Registry

clinicaltrials.gov

Start Date

July 2012

End Date

July 2014

Last Updated

11 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

ChromoLogic, LLC

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Subjects must be scheduled to receive whole body irradiation in a dose range from 1.5 to 12Gy.
•Subjects must not have received ocular surgery for at least three months prior to study enrolment.
•Subjects must not have a history of uveitis.
•Subjects must have at least one eye free of cataracts
•Subject age must be greater than 18 years
•Subjects must have the ability to understand and willingness to sign a written informed consent document.